Anti-Factor XIIIa antibody [IHC572] (STJA0042166)

SKU:
STJA0042166
£127.50 - £326.50
Processing The item has been added

Short Description :Rabbit monoclonal anti-Factor XIIIa for use in IHC-p in Human samples. Datasheet included with dilution recommendations, and related reagents.
Applications:IHC-p
Host:Rabbit
Reactivity:Human
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Monoclonal
Clone ID :IHC572
Conjugation:Unconjugated
Formulation:Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
Storage Instruction:Store at 2-8°C for up to 1 year. Do not freeze.
Specificity:Tested and validated on placenta, dermatofibroma tissue.
Background Factor XIIIa (FXIIIa) , also known as activated Factor XIII, is a blood coagulation factor that stabilizes fibrin and is present in monocytes, macrophages, platelets, megakaryocytes, dermal dendritic cells, and fibroblast-like mesenchymal or histiocytic cells in the placenta. Anti-Factor XIIIa is useful for distinguishing between dermatofibrosarcoma protuberans (±) , dermatofibroma (mostly +) , and desmoplastic malignant melanoma (-). Hemangioendothelioma, hemangiopericytoma, capillary hemagioblastoma, hepatocellular carcinoma, glomus tumour, xanthogranuloma, xanthoma, and meningioma all stain positively with Anti-Factor XIIIa.

Information sourced from Uniprot.org